Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 65862-528

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 65862-528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A pharmacokinetic interaction chart illustrating the effect of various interacting drugs on venlafaxine exposure. The graph shows fold changes in Cmax and AUC with 90% confidence intervals relative to a reference value of 1.0 for interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. Corresponding dosing recommendations or cautions are noted alongside the data points.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A forest plot chart depicting pharmacokinetic (PK) fold changes with 90% confidence intervals for various interacting drugs and analytes relative to a reference value. The chart includes data points for Cmax and AUC parameters, along with dosing recommendations or cautions for concurrent use. Interacting drugs include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A forest plot chart depicting pharmacokinetic (PK) changes and fold changes with 90% confidence intervals for venlafaxine in special populations, including hepatic impairment of varying severity, renal impairment, CYP2D6 polymorphism metabolizers, age over 60 years, and gender differences. The chart shows changes in venlafaxine Cmax, AUC, and ODV parameters and corresponding dosing recommendations.*

FDA Label Image

Package Label-principal Display Panel (37.5 mg (15 Capsule Bottle))

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 37.5 mg by Aurobindo Pharma Limited. The label specifies the dosage form as extended-release capsules containing 37.5 mg venlafaxine hydrochloride USP equivalent to 37.5 mg venlafaxine. It includes storage instructions and distributor information for Aurobindo Pharma USA, Inc. The package contains 15 capsules.*

FDA Label Image

Package Label-principal Display Panel (37.5 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules USP 37.5 mg from Aurobindo Pharma Limited. The label indicates a package size of 100 unit-dose capsules (10 x 10). The design features teal and dark blue accents with dosage strength prominently displayed on multiple sides.*

FDA Label Image

Package Label-principal Display Panel -75 mg (15 Capsule Bottle) (Venlafaxine Fig6)

Label of Venlafaxine Hydrochloride Extended-Release Capsules USP 75 mg by Aurobindo Pharma Limited. The label specifies 15 capsules per package, with storage instructions at 20° to 25°C, pharmacist dispensing guidance, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (75 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules USP 75 mg by Aurobindo Pharma Limited. The label shows a carton layout for 100 extended-release capsules, indicating the product is Rx only. The label includes dosing information, barcode, and manufacturer details.*

FDA Label Image

Package Label-principal Display Panel (150 mg (15 Capsule Bottle))

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg by Aurobindo Pharma Limited. The label states it is a prescription drug with a package count of 15 capsules. It includes storage instructions and distributor information for Aurobindo Pharma USA, Inc. The label also has a designated printing and coding area on the right side.*

FDA Label Image

Package Label-principal Display Panel (150 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 150 mg strength, capsules in a 100 count (10 x 10) unit-dose package. The label shows the brander as Aurobindo Pharma Limited and includes directions for pharmacists to dispense the medication guide separately. The label is primarily white with teal and blue accents and includes the NDC code 65862-697-10.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride, showing its molecular arrangement including a dimethylamino group, a methoxy-substituted aromatic ring, and a cyclohexanol moiety with the hydrochloride salt indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.